Hennepin Life Sciences

United States
Mercer, Maine, United States, 55447

Company profile

Hennepin Life Sciences company profile

Hennepin Life Sciences is a growth stage human and animal health company that is uniquely focused on the development of patent protected, novel, naturally-derived anti-infective compounds for the prevention and treatment of a wide array of infections. We created innovative nature-based therapies by combining molecular concepts of infection to clinical applications.Founded in 2009 from a technology transfer out of the University of Minnesota, Hennepin Life Sciences (HLS) is a Phase2 clinical trial stage, Minnesota -based biotechnology firm that continues to develop a patented approach to address the global super bug challenge. Today, HLS continues to expand its product platform intellectual property, advance the practical science through clinical studies and is active forging distribution partnerships to initially reach clinical application.

Business identity

Contact email
[email protected]
Phone number
+1 (612)840-9468
Operating status
Closed
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0+
Founded
2009-01-01, Year

Headquarters

Postal code
55447
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$1.9M
Last funding
Angel / $1.9M / 2017-03-07
Last equity funding
Angel / $1.9M
Founders
3

Founders and investors

Founders

Bill FaulknerDouglas WicksPatrick M. Schlievert